Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Hongrui Biotechnology is a life sciences company based in Tianjin, China, that specializes in the development and production of high-quality biological reagents and diagnostic raw materials. The company provides a wide range of products including recombinant proteins, monoclonal and polyclonal antibodies, and molecular biology enzymes to support academic research and industrial applications. In addition to its product catalog, Tianjin Hongrui offers contract research services (CRO) such as protein expression, purification, and antibody development. The firm focuses on serving the biotechnology, pharmaceutical, and clinical diagnostic sectors with standardized and customized solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Hongrui Biotechnology.